A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)

BJU International
Marco RandazzoMaciej Kwiatkowski

Abstract

To assess the value of a positive family history (FH) as a risk factor for prostate cancer incidence and grade among men undergoing organised prostate-specific antigen (PSA) screening in a population-based study. The study cohort comprised all attendees of the Swiss arm of the European Randomised Study of Screening for Prostate Cancer (ERSPC) with systematic PSA level tests every 4 years. Men reporting first-degree relative(s) diagnosed with prostate cancer were considered to have a positive FH. Biopsy was exclusively PSA triggered at a PSA level threshold of 3 ng/mL. The primary endpoint was prostate cancer diagnosis. Kaplan-Meier and Cox regression analyses were used. Of 4 932 attendees with a median (interquartile range, IQR) age of 60.9 (57.6-65.1) years, 334 (6.8%) reported a positive FH. The median (IQR) follow-up duration was 11.6 (10.3-13.3) years. Cumulative prostate cancer incidence was 60/334 (18%, positive FH) and 550/4 598 (12%, negative FH) [odds ratio 1.6, 95% confidence interval (CI) 1.2-2.2, P = 0.001). In both groups, most prostate cancer diagnosed was low grade. There were no significant differences in PSA level at diagnosis, biopsy Gleason score or Gleason score on pathological specimen among men who underwe...Continue Reading

References

Jun 5, 2003·BJU International·L E Johns, R S Houlston
Oct 21, 2003·International Journal of Cancer. Journal International Du Cancer·Deborah Watkins BrunerPaul Engstrom
Apr 20, 2006·Journal of the National Cancer Institute·Ian M ThompsonCharles A Coltman
Jul 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick A KupelianEric A Klein
Sep 19, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Scott D RamseyMuin J Khoury
Nov 7, 2006·The Journal of Urology·Kimberly A RoehlWilliam J Catalona
Apr 24, 2007·International Journal of Cancer. Journal International Du Cancer·Edward GiovannucciWalter C Willett
Feb 2, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayE Steliarova-Foucher
Apr 2, 2010·The New England Journal of Medicine·Gerald L AndrioleUNKNOWN REDUCE Study Group
Aug 21, 2010·Journal of the National Cancer Institute·Ola BrattPär Stattin
Sep 21, 2010·European Urology·Maarten C BoslandLambertus A Kiemeney
Mar 16, 2012·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators
Apr 26, 2012·The American Journal of Surgical Pathology·Hillary M RossJonathan I Epstein
May 11, 2013·The Journal of Urology·H Ballentine CarterAnthony L Zietman
Oct 8, 2013·BMC Health Services Research·Kirsten HowardMichael P Pignone
Oct 24, 2013·BJU International·Jennifer L Beebe-DimmerKathleen A Cooney
Nov 12, 2013·European Urology·Axel HeidenreichUNKNOWN European Association of Urology
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Mar 5, 2014·International Journal of Cancer. Journal International Du Cancer·Christoph FrankKari Hemminki
Oct 3, 2014·International Journal of Cancer. Journal International Du Cancer·Lasse SaarimäkiAnssi Auvinen
Jan 6, 2015·International Journal of Cancer. Journal International Du Cancer·Jaquelyn L JahnMeir J Stampfer
Jan 8, 2015·International Journal of Cancer. Journal International Du Cancer·Marco RandazzoMaciej Kwiatkowski

❮ Previous
Next ❯

Citations

Mar 13, 2016·BJU International·Christina G Selkirk, Brian T Helfand
Jul 23, 2020·Nature Reviews. Urology·David Eldred-EvansHashim U Ahmed
May 17, 2019·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Belinda F Morrison, Yulit Gordon
Nov 21, 2018·Diseases·Souheila AmorDominique Delmas
Jan 25, 2021·Familial Cancer·Holly Ni Raghallaigh, Rosalind Eeles
Mar 16, 2021·Der Urologe. Ausg. A·V H MeissnerK Herkommer
Apr 7, 2021·Urology·Deepansh Dalela, Firas Abdollah

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.